Detalhe da pesquisa
1.
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.
Nature
; 458(7238): 636-40, 2009 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-19287373
2.
Broad HIV-1 neutralization mediated by CD4-binding site antibodies.
Nat Med
; 13(9): 1032-4, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17721546
3.
Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site.
J Biol Chem
; 287(8): 5673-86, 2012 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22167180
4.
Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection.
Nat Commun
; 13(1): 2263, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477725
5.
Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site.
PLoS Pathog
; 5(5): e1000445, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19478876
6.
Selective expansion of HIV-1 envelope glycoprotein-specific B cell subsets recognizing distinct structural elements following immunization.
J Immunol
; 183(5): 3373-82, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19696434
7.
Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals.
J Virol
; 83(2): 1045-59, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19004942
8.
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies.
J Virol
; 83(1): 188-99, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18922865
9.
Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity.
Vaccine
; 21(27-30): 4275-84, 2003 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14505910